Clinical Trial Update: Treatment of Alcohol-Related Hepatitis With Arginine [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating L-Arginine for alcoholic hepatitis was withdrawn; no results or further updates are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Hepatitis

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Alcoholic Hepatitis | Phase 2 | Status: WITHDRAWN